Literature DB >> 2698813

Antecedents of cell aging research.

L Hayflick1.   

Abstract

Our observation that normal human and animal cells have a limited capacity to divide and function in vitro overturned a dogma held since the turn of the century. The dogma held that cultured normal cells are immortal and gerontologists interpreted this to mean that aging, therefore, could not be the result of intracellular events. We concluded that longevity and aging do result from intracellular events, and, in the subsequent 30 years, the validity of our finding has been widely confirmed. Other major findings have been made: (a) The number of population doublings and functional events that a cultured normal cell can undergo is inversely proportional to donor age and, probably, directly proportional to species longevity; (b) the limit on cell division and function also occurs in vivo when normal cells are transplanted seriatim; (c) as cell doublings or functional events reach their limit, changes occur in hundreds of variables from the molecular to the whole cell. Most importantly, many of these changes are identical to those seen in intact humans and animals as they age; (d) WI-38, the first widely distributed normal human cell strain has retained its memory of population doubling level during 27 years of cryogenic storage. This is the longest time that any normal human cell has ever been preserved. Evidence that longevity is determined by genetic events is overwhelming but evidence that age changes are the result of gene expression is not. Normal age changes must be distinguished from disease. Because few feral animals ever become old, natural selection could not have favored the development of a genetically programmed aging process. In the 2 or 3 million years of human existence, too few old humans existed to have provided a selective advantage favoring the development of a genetic program that would determine age changes. The selective advantage of maintaining physiological vigor for as long as possible in order to insure maximum reproductive success may be the essential indirect determinant of longevity. Natural selection has provided sexually mature animals with extraordinary reserve capacities in virtually all organs. After sexual maturation, animals continue to function by utilizing the reserve capacity that evolved to insure that they would attain reproductive success. The magnitude of reserve capacity is the essential element in determining postdevelopmental longevity. Thus "Why do we age?" may be the wrong question. The right question may be "Why do we live as long as we do?"

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2698813     DOI: 10.1016/0531-5565(89)90043-0

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  11 in total

1.  Morphological and morphometric study of early changes in the ageing golden hamster testis.

Authors:  R Horn; L M Pastor; E Moreno; A Calvo; M Canteras; J Pallares
Journal:  J Anat       Date:  1996-02       Impact factor: 2.610

2.  Ex vivo expansion and pluripotential differentiation of cryopreserved human bone marrow mesenchymal stem cells.

Authors:  Ying Xiang; Qiang Zheng; Bing-bing Jia; Guo-ping Huang; Yu-lin Xu; Jin-fu Wang; Zhi-jun Pan
Journal:  J Zhejiang Univ Sci B       Date:  2007-02       Impact factor: 3.066

3.  Quantifying T lymphocyte turnover.

Authors:  Rob J De Boer; Alan S Perelson
Journal:  J Theor Biol       Date:  2013-01-09       Impact factor: 2.691

Review 4.  The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing.

Authors:  Cynthia Kenyon
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-01-12       Impact factor: 6.237

5.  Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation.

Authors:  Birgit Kulterer; Gerald Friedl; Anita Jandrositz; Fatima Sanchez-Cabo; Andreas Prokesch; Christine Paar; Marcel Scheideler; Reinhard Windhager; Karl-Heinz Preisegger; Zlatko Trajanoski
Journal:  BMC Genomics       Date:  2007-03-12       Impact factor: 3.969

6.  Aging of mesenchymal stem cells: Implication in regenerative medicine.

Authors:  Yueh-Hsun Kevin Yang
Journal:  Regen Ther       Date:  2018-11-03       Impact factor: 3.419

7.  Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro.

Authors:  Yueh-Hsun Kevin Yang; Courtney R Ogando; Carmine Wang See; Tsui-Yun Chang; Gilda A Barabino
Journal:  Stem Cell Res Ther       Date:  2018-05-11       Impact factor: 6.832

8.  AFM-based Analysis of Wharton's Jelly Mesenchymal Stem Cells.

Authors:  Renata Szydlak; Marcin Majka; Małgorzata Lekka; Marta Kot; Piotr Laidler
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923

Review 9.  Principal Criteria for Evaluating the Quality, Safety and Efficacy of hMSC-Based Products in Clinical Practice: Current Approaches and Challenges.

Authors:  Juan Antonio Guadix; Javier López-Beas; Beatriz Clares; José Luis Soriano-Ruiz; José Luis Zugaza; Patricia Gálvez-Martín
Journal:  Pharmaceutics       Date:  2019-10-24       Impact factor: 6.321

10.  Back to the Cradle of Cytotherapy: Integrating a Century of Clinical Research and Biotechnology-Based Manufacturing for Modern Tissue-Specific Cellular Treatments in Switzerland.

Authors:  Alexis Laurent; Philippe Abdel-Sayed; Corinne Scaletta; Philippe Laurent; Elénie Laurent; Murielle Michetti; Anthony de Buys Roessingh; Wassim Raffoul; Nathalie Hirt-Burri; Lee Ann Applegate
Journal:  Bioengineering (Basel)       Date:  2021-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.